Medtech Innovation And Reinvention Is Part Of The Swiss DNA

Switzerland‘s Medtech And Healthtech Footprint is Growing In All Industrial And Research Areas

Focus On Switzerland – Part 1: Switzerland is a high-tech microcosm of the medtech industry. It is home to the EMEA headquarters of the world’s largest medtech group, Medtronic, and supports a vibrant SME and start-up community, in the example of hybrid soft tissue robotics company Distalmotion. In Vivo interviewed both for this feature on the contribution of Swiss medtech in the advancement of patient care, domestically and globally.

Bardocz Peter

Swiss medtech is transitioning into the next era of innovation, building on traditional strengths in whole supply chain, discovery, commercial, R&D, production and clinical trials. So says Switzerland Global Enterprise (SGE) director of investment promotion Sirpa Tsimal. “A lot of companies set up a regional headquarters, not just for the Swiss market but also as a hub for Europe or EMEA,” she said.

Medtronic plc is the biggest and probably the most visible example, having moved from Brussels, Belgium to set up...

More from Global Vision

More from In Vivo

Turning Defense Into Attack: Snapshots Of A Changing Medtech Market And How To Respond

 
• By 

Against a backdrop of shifting trade policies, the end of multilateral market approaches and renewed focus on supply chain resilience, medtechs are doubling down on innovation in products and processes – using AI – and keeping unmet needs and outcomes in the center of the target.

AI Agents Set To Reshape Biopharma’s Workforce And Operations

 
• By 

While biopharma companies experiment with genAI, agentic AI is rapidly shifting the work paradigm towards one of autonomous digital workers that can handle entire process flows.

MitoRx’s Muscle-Preserving Obesity Drug Takes Aim At GLP-1 Limitations

 
• By 

UK biotech targets the root cause of metabolic disease while preserving muscle mass in a crowded obesity market.